JPM23: With preclinical gene writing data on display, Tessera CEO's spirits not dampened by...
It may have been one long, wet week at the 2023 J.P. | Experiments in mice, primates and human cells showed that Tessera's technology could edit and engineer genes to restore enzyme function, produce...